Campbell David Alan
Janux Therapeutics, Inc. · President and CEO
Campbell David Alan is listed in public filings as director, officer: President and CEO. This Campbell David Alan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Janux Therapeutics, Inc. (JANX). Investors use Campbell David Alan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $300k5k shares | SellJan 7, 2025 | $60.00 | $14.44 | |
| $1.4M25k shares | SellDec 24, 2024 | $56.19 | $14.44 | |
| $1.0M15k shares | SellDec 3, 2024 | $67.00 | $14.44 | |
| $940k18.3k shares | SellNov 25, 2024 | $51.43 | $14.44 | |
| $350k6.7k shares | SellNov 25, 2024 | $52.04 | $14.44 | |
| $740k13.9k shares | SellOct 28, 2024 | $53.22 | $14.44 | |
| $599k11.1k shares | SellOct 28, 2024 | $53.94 | $14.44 | |
| $874k19k shares | SellSep 27, 2024 | $46.09 | $14.44 | |
| $246k5.2k shares | SellSep 27, 2024 | $46.86 | $14.44 | |
| $38k795 shares | SellSep 27, 2024 | $47.84 | $14.44 |